Skip to main content

Research Repository

Advanced Search

Recommendations for wider adoption of clinical pharmacy in Central and Eastern Europe in order to optimise pharmacotherapy and improve patient outcomes

Urbańczyk, Kamila; Guntschnig, Sonja; Antoniadis, Vasilis; Falamic, Slaven; Kovacevic, Tijana; Kurczewska-Michalak, Marta; Miljković, Branislava; Olearova, Anna; Sviestina, Inese; Szucs, Attila; Tachkov, Konstantin; Tiszai, Zita; Volmer, Daisy; Wiela-Hojeńska, Anna; Fialova, Daniela; Vlcek, Jiri; Stuhec, Matej; Hogg, Anita; Scott, Michael; Stewart, Derek; Mair, Alpana; Ravera, Silvia; Lery, François-Xavier; Kardas, Przemysław

Authors

Kamila Urbańczyk

Sonja Guntschnig

Vasilis Antoniadis

Slaven Falamic

Tijana Kovacevic

Marta Kurczewska-Michalak

Branislava Miljković

Anna Olearova

Inese Sviestina

Attila Szucs

Konstantin Tachkov

Zita Tiszai

Daisy Volmer

Anna Wiela-Hojeńska

Daniela Fialova

Jiri Vlcek

Matej Stuhec

Anita Hogg

Michael Scott

Derek Stewart

Silvia Ravera

François-Xavier Lery

Przemysław Kardas



Abstract

Clinical pharmacy as an area of practice, education and research started developing around the 1960s when pharmacists across the globe gradually identified the need to focus more on ensuring the appropriate use of medicines to improve patient outcomes rather than being engaged in manufacturing and supply. Since that time numerous studies have shown the positive impact of clinical pharmacy services (CPS). The need for wider adoption of CPS worldwide becomes urgent, as the global population ages, and the prevalence of polypharmacy as well as shortage of healthcare professionals is rising. At the same time, there is great pressure to provide both high-quality and cost-effective health services. All these challenges urgently require the adoption of a new paradigm of healthcare system architecture. One of the most appropriate answers to these challenges is to increase the utilization of the potential of highly educated and skilled professionals widely available in these countries, i.e., pharmacists, who are well positioned to prevent and manage drug-related problems together with ensuring safe and effective use of medications with further care relating to medication adherence. Unfortunately, CPS are still underdeveloped and underutilized in some parts of Europe, namely, in most of the Central and Eastern European (CEE) countries. This paper reviews current situation of CPS development in CEE countries and the prospects for the future of CPS in that region.

Citation

Urbańczyk, K., Guntschnig, S., Antoniadis, V., Falamic, S., Kovacevic, T., Kurczewska-Michalak, M., Miljković, B., Olearova, A., Sviestina, I., Szucs, A., Tachkov, K., Tiszai, Z., Volmer, D., Wiela-Hojeńska, A., Fialova, D., Vlcek, J., Stuhec, M., Hogg, A., Scott, M., Stewart, D., …Kardas, P. (2023). Recommendations for wider adoption of clinical pharmacy in Central and Eastern Europe in order to optimise pharmacotherapy and improve patient outcomes. Frontiers in Pharmacology, 14, Article 1244151. https://doi.org/10.3389/fphar.2023.1244151

Journal Article Type Article
Acceptance Date Jul 17, 2023
Online Publication Date Aug 2, 2023
Publication Date 2023
Deposit Date Jan 31, 2024
Publicly Available Date Jan 31, 2024
Journal Frontiers in Pharmacology
Publisher Frontiers Media
Peer Reviewed Peer Reviewed
Volume 14
Article Number 1244151
Item Discussed Medicines management and Clinical Pharmacy Services
DOI https://doi.org/10.3389/fphar.2023.1244151
Keywords clinical pharmacy, cost-effective treatment, medication errors, drug utilization, drug safety, medication adherence, health policy, polypharmacy
Public URL http://researchrepository.napier.ac.uk/Output/3497254

Files





You might also like



Downloadable Citations